What is the most appropriate management for a 24‑week + 2‑day pregnant patient with fetal growth restriction and persistent absent end‑diastolic flow in the umbilical arteries?

Management of FGR with Absent End-Diastolic Flow at 24 Weeks

At 24 weeks + 2 days with FGR and persistent absent end-diastolic flow (AEDF), expectant management with intensive surveillance is the appropriate approach, NOT immediate delivery, given the extremely poor neonatal outcomes at this gestational age.

Critical Context: The Periviable Period Challenge

At 24 weeks with AEDF, you are facing one of obstetrics' most difficult scenarios. The data are sobering: intact survival is 0% at 24 weeks and only 13% at 25 weeks for early-onset FGR with abnormal Doppler studies 1. Neonatal survival at 24 weeks is only 13%, increasing to 43% at 25 weeks and 58-76% at 26 weeks 1.

Immediate Management Steps

1. Multidisciplinary Coordination (Within 24-48 Hours)

• Mandatory consultation with maternal-fetal medicine and neonatology 1
• Transfer to tertiary center with highest-level NICU if not already there 2
• Comprehensive counseling on realistic outcomes: near-zero intact survival at current gestational age

2. Diagnostic Workup

• Detailed anatomic ultrasound (CPT 76811) to identify structural anomalies 1
• Offer chromosomal microarray analysis via amniocentesis for unexplained early-onset FGR <32 weeks (GRADE 1C) 1
• CMV PCR testing if amniocentesis performed 1
• Do NOT routinely screen for toxoplasmosis, rubella, or herpes without other risk factors 1

3. Surveillance Protocol for AEDF

Doppler Assessment:

• Umbilical artery Doppler 2-3 times per week (GRADE 1C) 1
• Monitor for progression to reversed end-diastolic flow (REDF)
• Recent data show AEDF progresses to REDF in approximately 6±6 days 3

Cardiotocography (CTG):

• Increased frequency testing when AEDF present (GRADE 2C) 1
• For early FGR <32 weeks, computerized CTG (cCTG) with short-term variation (STV) monitoring is superior to visual CTG 2
• The TRUFFLE trial demonstrated best 2-year neurodevelopmental outcomes (95% intact survival) using late ductus venosus changes plus cCTG-STV safety net 2

Ductus Venosus Monitoring:

• While not routinely recommended for all FGR, ductus venosus Doppler becomes critical in early-onset FGR with AEDF 2
• All fetal deaths in recent studies showed either REDF or abnormal ductus venosus before demise 3

Delivery Timing Decision Algorithm

Current Gestational Age (24+2 weeks): Expectant Management

Goal: Reach at least 26 weeks if possible

The guideline threshold of 26 weeks or 500g has been suggested for severe early-onset FGR 1. However, this is not absolute—it requires shared decision-making with the family.

Delivery Indications by Gestational Age:

Before 26 weeks:

• Only if maternal indication (severe preeclampsia, HELLP syndrome)
• Or if family chooses intervention after comprehensive counseling
• Fetal indications alone generally do NOT warrant delivery given dismal outcomes

26-30 weeks with AEDF:

• Continue expectant management with intensive surveillance
• Prepare for delivery if progression to REDF (recommended delivery 30-32 weeks for REDF, GRADE 1B) 1

30-32 weeks with REDF:

• Deliver at 30-32 weeks (GRADE 1B) 1

33-34 weeks with persistent AEDF:

• Deliver at 33-34 weeks (GRADE 1B) 1
• Neonatal morbidity/mortality from AEDF exceeds prematurity risks at this gestational age

Acute Deterioration Triggers (Any Gestational Age ≥26 weeks):

If REDF develops:

• Hospitalize immediately (GRADE 2C) 1
• Administer antenatal corticosteroids 1
• cCTG monitoring at least 1-2 times daily (GRADE 2C) 1
• Consider delivery based on complete clinical picture 1

Antenatal Interventions

Corticosteroids:

• Administer if delivery anticipated before 33 6/7 weeks (GRADE 1A) 1
• Given the high likelihood of early delivery with AEDF at 24 weeks, consider administration now if family opts for intervention at viability

Magnesium Sulfate:

• Administer for neuroprotection if delivery <32 weeks (GRADE 1A) 1

Mode of Delivery Considerations

Cesarean delivery should be strongly considered for FGR with AEDF/REDF (GRADE 2C) 1. Historical data show 75-95% of these cases require cesarean for intrapartum fetal heart rate decelerations 1. Growth-restricted fetuses with AEDF/REDF are at high risk for:

• Intrapartum decelerations
• Emergency cesarean
• Metabolic acidemia at delivery

Critical Pitfalls to Avoid

1. Do NOT deliver immediately at 24 weeks based on AEDF alone—outcomes are catastrophic
2. Do NOT rely on visual CTG alone in early FGR—use cCTG with STV if available 2
3. Do NOT miss the window for corticosteroids—AEDF can progress rapidly (median 6 days to REDF) 3
4. Do NOT ignore ductus venosus changes—all fetal deaths showed DV abnormalities or REDF before demise 3
5. Do NOT attempt vaginal delivery without careful consideration—cesarean is often necessary

Realistic Prognostic Counseling

Be transparent with the family:

• At 24 weeks with AEDF: 13% survival, 0% intact survival 1
• Each week gained significantly improves outcomes
• If reaching 26 weeks: 58-76% survival, 6-31% intact survival 1
• Risk of stillbirth increases with Doppler severity: 0.6% with intermittent AEDF to 11.5% with REDF 3

The decision to pursue aggressive management versus comfort care is deeply personal and requires shared decision-making with full disclosure of these statistics.